Santoshi Billakota, MD
Neurology · Corona
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
- Since medical school
- 14 years
- Graduated 2012
Offices
2 locations · Cep America - Neurology PC · Wyckoff Professional Medical Services PC
Hospitals listed: Wyckoff Heights Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Billakota’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A150153 · Current
Licensed to practise in California · since 2017 · expires 2027-05-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Clinical Neurophysiology
- American Board of Psychiatry and Neurology - Epilepsy
- American Board of Psychiatry and Neurology - Neurology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Wyckoff Heights Medical CenterBrooklyn, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPatients rate it 2 of 5 · 62% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.605, Oct 2024 – Sep 2025
See every measure and the patient survey for Wyckoff Heights Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.605 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.07) · 362 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.55 to 1.39) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.4 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.9 · 157 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.9 · 146 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 2,150 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.09 to 0.53) · 2,250 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,313 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (0.63 to 5.64) · 237 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0 to 3.4) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.8 to 4.13) · 254 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.74 (0 to 18.57) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.18 (0.86 to 9.5) · 34 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 53 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0 to 1.49) · 1,785 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 39 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.94 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.582 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.3 · 459 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 5.7 · 95 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 66.6 · 157 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 482 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.9 · 261 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.4) · 74 cases | No different | Jan 2022 – Dec 2024 |
What patients said (847 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 47% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 62% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 62% |
| Staff "always" explained possible side effects | 33% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$26,562
Medicare paid this office $26,562 for 223 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 61 | $6,531 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $5,868 | $136 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,325 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,155 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,775 | $93 |
See all 9 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 61 | $6,531 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $5,868 | $136 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,325 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,155 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,775 | $93 |
| Short return visit (20+ min) | 17 | $1,023 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $815 | $58 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $733 | $67 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $721 | $42 |
Who their Medicare patients are
223 Original Medicare patients in 2024. Average age 75 · Under 65 11% · 85 and older 20% · Women 53% · Also on Medicaid 51% · Health risk score 2.24. Above the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Stroke 65% · Diabetes 52% · Chronic kidney disease 42% · Heart failure 39% · Depression 37% · Coronary heart disease 35% · Atrial fibrillation 35% · Dementia 30% · COPD 26% · Cancer 15%.
The office billed $140,395, Medicare allowed $33,873 and paid $26,562; for 286 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 223 | 286 | 75 | 2.24 | $140,395 | $26,562 |
| 2023 | 154 | 424 | 68 | 1.79 | $138,097 | $24,934 |
| 2022 | 247 | 449 | 64 | 1.83 | $295,193 | $58,351 |
| 2021 | 270 | 650 | 65 | 1.73 | $429,098 | $81,304 |
| 2020 | 153 | 291 | 64 | 2.06 | $172,967 | $34,675 |
| 2019 | 211 | 519 | 66 | 1.92 | $522,691 | $84,264 |
| 2018 | 86 | 141 | 69 | 1.95 | $116,615 | $20,984 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 19 | $6,903 | $182 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,098 | $141 |
| Return visit (30+ min) | 37 | $2,893 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,256 | $64 |
2022: 8 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 88 | $31,766 | $190 |
| Return visit (30+ min) | 74 | $9,546 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,533 | $65 |
| Short return visit (20+ min) | 33 | $2,616 | $75 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 20 | $2,501 | $125 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,998 | $125 |
| Measurement of brain wave activity (eeg), awake and drowsy | 19 | $884 | $47 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 11 | $520 | $47 |
2021: 9 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 122 | $44,850 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $9,820 | $65 |
| Return visit (30+ min) | 46 | $5,975 | $100 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 34 | $4,402 | $126 |
| Measurement of brain wave activity (eeg), 37-60 hours with health care professional review and report | 24 | $4,095 | $171 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,720 | $124 |
| Short return visit (20+ min) | 19 | $1,561 | $74 |
| Measurement of brain wave activity (eeg), awake and drowsy | 28 | $1,429 | $51 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 16 | $741 | $46 |
2020: 9 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 50 | $17,199 | $195 |
| Short return visit (20+ min) | 29 | $2,467 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,812 | $67 |
| Return visit (30+ min) | 17 | $1,540 | $73 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 12 | $1,517 | $126 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,424 | $129 |
| Long return visit (40+ min) | 12 | $1,286 | $107 |
| Hospital discharge day management, 30 minutes or less | 13 | $886 | $68 |
| Measurement of brain wave activity (eeg), awake and drowsy | 12 | $428 | $36 |
2019: 10 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 96 | $58,808 | $284 |
| Monitoring and localization of seizure activity over 24-hour period using portable 16-channel electroencephalograph (EEG) | 23 | $5,952 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $5,290 | $62 |
| Return visit (30+ min) | 18 | $2,496 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,489 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,682 | $112 |
| Measurement of brain wave activity (eeg), awake and drowsy | 28 | $1,471 | $53 |
| Long return visit (40+ min) | 11 | $1,309 | $119 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 16 | $782 | $49 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 12 | $622 | $52 |
2018: 2 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 28 | $12,313 | $286 |
| Measurement of brain wave activity (eeg), awake and drowsy | 19 | $984 | $52 |
Medicaid work
$2,983 in 2024
Medicaid paid $2,983 for 72 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 29 | $1,711 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 31 | $844 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $428 |
| 2024 | 72 | 3 | 15 | $2,983 |
| 2023 | 105 | 4 | 16 | $7,130 |
| 2022 | 101 | 2 | 18 | $6,129 |
| 2021 | 117 | 2 | 20 | $10,434 |
| 2020 | 106 | 3 | 21 | $6,202 |
| 2019 | 87 | 2 | 17 | $14,784 |
See the largest Medicaid services in earlier years
2023
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 27 | $3,053 |
| Return visit (30+ min) | 45 | $2,469 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 14 | $838 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 19 | $770 |
2022
| Return visit (30+ min) | 72 | $4,162 |
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 29 | $1,967 |
2021
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 26 | $5,240 |
| Return visit (30+ min) | 91 | $5,194 |
2020
| Short return visit (20+ min) | 75 | $2,681 |
| Short return visit | 12 | $2,117 |
| Return visit (30+ min) | 19 | $1,404 |
2019
| Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours | 70 | $11,743 |
| Short return visit (20+ min) | 17 | $3,040 |
Drugs they prescribed that Part D paid
$34,234
Pharmacies billed $34,234 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 311) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
280 generic and fewer than 11 brand-name prescriptions · $34,234 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Emgality | Migraine | 12 | $7,856 | $655 |
| Levetiracetam | None | 40 | $1,265 | $32 |
| Divalproex | None | 13 | $611 | $47 |
| Gabapentin | None | 29 | $509 | $18 |
| Carbidopa-Levodopa | None | 19 | $499 | $26 |
See all 9 drugs
| Emgality | Migraine | 12 | $7,856 | $655 |
| Levetiracetam | None | 40 | $1,265 | $32 |
| Divalproex | None | 13 | $611 | $47 |
| Gabapentin | None | 29 | $509 | $18 |
| Carbidopa-Levodopa | None | 19 | $499 | $26 |
| Primidone | None | 18 | $396 | $22 |
| Topiramate | None | 25 | $341 | $14 |
| Donepezil | None | 16 | $188 | $12 |
| Lamotrigine | None | 17 | $167 | $10 |
Year by year
| 2024 | 311 | 95 | 0% (0) | None | $34,234 |
| 2023 | 978 | 142 | 0% (0) | None | $577,972 |
| 2022 | 1,929 | 186 | 0% (0) | 27% | $1,143,004 |
| 2021 | 1,123 | 124 | 0% (0) | 29% | $508,331 |
| 2020 | 669 | 65 | 0% (0) | 24% | $309,901 |
| 2019 | 334 | 58 | 0% (0) | None | $65,345 |
| 2018 | 195 | 49 | 0% (0) | None | $79,538 |
| 2017 | 154 | 24 | 0% (0) | 32% | $79,759 |
| 2016 | 101 | 20 | 0% (0) | None | $35,329 |
| 2015 | 144 | 29 | None | 24% | $45,010 |
| 2014 | 161 | 34 | None | None | $27,983 |
| 2013 | 172 | 53 | None | None | $15,062 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Epidiolex | 27 | $179,456 | $6,647 |
| Vimpat | 31 | $49,153 | $1,586 |
| Aptiom | 18 | $39,444 | $2,191 |
| Lamotrigine Er | 89 | $37,553 | $422 |
| Lacosamide | 62 | $16,367 | $264 |
| Felbamate | 27 | $14,228 | $527 |
| Levetiracetam | 128 | $12,566 | $98 |
| Clobazam | 41 | $8,825 | $215 |
| Divalproex Sodium Er | 42 | $6,677 | $159 |
| Levetiracetam Er | 25 | $3,067 | $123 |
| Divalproex | 41 | $2,347 | $57 |
| Dilantin | 11 | $2,224 | $202 |
| Lamotrigine | 68 | $1,780 | $26 |
| Valproic Acid | 11 | $1,660 | $151 |
| Oxcarbazepine | 18 | $1,353 | $75 |
| Topiramate | 40 | $1,086 | $27 |
| Zonisamide | 23 | $767 | $33 |
| Phenytoin Sodium Extended | 11 | $328 | $30 |
| Clonazepam | 15 | $261 | $17 |
| Phenytoin | 14 | $112 | $8 |
2022: 36 drugs
| Epidiolex | 36 | $201,699 | $5,603 |
| Vimpat | 153 | $200,350 | $1,309 |
| Aptiom | 44 | $79,258 | $1,801 |
| Keppra | 30 | $53,068 | $1,769 |
| Lamictal Xr | 11 | $48,856 | $4,441 |
| Xcopri | 33 | $41,457 | $1,256 |
| Zonegran | 17 | $41,213 | $2,424 |
| Lamotrigine Er | 120 | $38,936 | $324 |
| Lacosamide | 103 | $35,183 | $342 |
| Clobazam | 147 | $35,158 | $239 |
| Fycompa | 23 | $26,833 | $1,167 |
| Felbatol | 13 | $26,442 | $2,034 |
| Felbamate | 59 | $26,053 | $442 |
| Keppra Xr | 14 | $21,834 | $1,560 |
| Lamictal | 12 | $20,688 | $1,724 |
| Topamax | 12 | $20,166 | $1,681 |
| Divalproex Sodium Er | 73 | $10,512 | $144 |
| Qudexy Xr | 13 | $9,658 | $743 |
| Levetiracetam | 186 | $9,561 | $51 |
| Nayzilam | 13 | $8,660 | $666 |
| Rufinamide | 12 | $7,597 | $633 |
| Levetiracetam Er | 47 | $5,044 | $107 |
| Divalproex | 63 | $4,404 | $70 |
| Lamotrigine | 162 | $3,626 | $22 |
| Oxcarbazepine | 25 | $2,857 | $114 |
| Phenobarbital | 39 | $2,347 | $60 |
| Clonazepam | 89 | $1,613 | $18 |
| Dilantin | 11 | $1,535 | $140 |
| Zonisamide | 43 | $1,298 | $30 |
| Levocarnitine | 14 | $1,252 | $89 |
| Topiramate | 44 | $1,007 | $23 |
| Phenytoin Sodium Extended | 22 | $448 | $20 |
| Lorazepam | 18 | $321 | $18 |
| Gabapentin | 11 | $230 | $21 |
| Phenytoin | 19 | $151 | $8 |
| Paroxetine | 16 | $69 | $4 |
2021: 28 drugs
| Vimpat | 133 | $147,118 | $1,106 |
| Banzel | 11 | $43,200 | $3,927 |
| Zonegran | 14 | $33,134 | $2,367 |
| Aptiom | 18 | $28,120 | $1,562 |
| Xcopri | 25 | $23,846 | $954 |
| Topamax | 14 | $22,692 | $1,621 |
| Keppra Xr | 13 | $18,614 | $1,432 |
| Keppra | 20 | $17,299 | $865 |
| Felbamate | 38 | $14,627 | $385 |
| Divalproex Sodium Er | 77 | $11,621 | $151 |
| Lamotrigine Er | 61 | $11,184 | $183 |
| Qudexy Xr | 13 | $9,305 | $716 |
| Clobazam | 87 | $6,693 | $77 |
| Levetiracetam | 99 | $4,666 | $47 |
| Pregabalin | 12 | $2,689 | $224 |
| Carbamazepine | 14 | $2,660 | $190 |
| Divalproex | 33 | $2,125 | $64 |
| Lamotrigine | 117 | $2,110 | $18 |
| Oxcarbazepine | 28 | $1,871 | $67 |
| Phenobarbital | 38 | $1,613 | $42 |
| Zonisamide | 26 | $1,447 | $56 |
| Levocarnitine | 14 | $1,032 | $74 |
| Clonazepam | 37 | $557 | $15 |
| Topiramate | 28 | $451 | $16 |
| Levetiracetam Er | 11 | $346 | $31 |
| Phenytoin Sodium Extended | 16 | $336 | $21 |
| Gabapentin | 18 | $225 | $13 |
| Phenytoin | 13 | $158 | $12 |
2020: 18 drugs
| Epidiolex | 16 | $89,449 | $5,591 |
| Vimpat | 62 | $61,760 | $996 |
| Aptiom | 29 | $36,396 | $1,255 |
| Banzel | 16 | $35,982 | $2,249 |
| Lamotrigine Er | 54 | $12,661 | $234 |
| Felbamate | 25 | $10,785 | $431 |
| Clobazam | 68 | $8,715 | $128 |
| Qudexy Xr | 12 | $8,112 | $676 |
| Levetiracetam | 115 | $4,396 | $38 |
| Divalproex Sodium Er | 32 | $4,212 | $132 |
| Pregabalin | 12 | $2,091 | $174 |
| Lamotrigine | 62 | $748 | $12 |
| Phenobarbital | 14 | $393 | $28 |
| Quetiapine | 14 | $289 | $21 |
| Clonazepam | 26 | $285 | $11 |
| Topiramate | 11 | $255 | $23 |
| Phenytoin Sodium Extended | 12 | $199 | $17 |
| Gabapentin | 11 | $80 | $7 |
2019: 9 drugs
| Onfi | 15 | $12,821 | $855 |
| Felbamate | 13 | $4,083 | $314 |
| Lamotrigine Er | 22 | $4,060 | $185 |
| Levetiracetam | 71 | $2,092 | $29 |
| Clobazam | 13 | $1,989 | $153 |
| Divalproex Sodium Er | 21 | $1,179 | $56 |
| Lamotrigine | 44 | $705 | $16 |
| Topiramate | 17 | $211 | $12 |
| Gabapentin | 19 | $152 | $8 |
2018: 3 drugs
| Vimpat | 36 | $28,598 | $794 |
| Onfi | 14 | $18,839 | $1,346 |
| Lamotrigine | 54 | $505 | $9 |
2017: 6 drugs
| Lamictal Xr | 12 | $25,066 | $2,089 |
| Vimpat | 14 | $7,136 | $510 |
| Carbamazepine Er | 16 | $4,578 | $286 |
| Levetiracetam Er | 18 | $1,841 | $102 |
| Levetiracetam | 19 | $399 | $21 |
| Lamotrigine | 34 | $362 | $11 |
2016: 1 drug
| Vimpat | 14 | $11,960 | $854 |
2015: 4 drugs
| Onfi | 12 | $14,176 | $1,181 |
| Vimpat | 12 | $10,645 | $887 |
| Amitriptyline | 16 | $326 | $20 |
| Gabapentin | 12 | $132 | $11 |
2014: 5 drugs
| Carbidopa-Levodopa | 13 | $1,345 | $103 |
| Gabapentin | 14 | $400 | $29 |
| Atorvastatin | 16 | $360 | $23 |
| Oxcarbazepine | 12 | $235 | $20 |
| Amitriptyline | 14 | $62 | $4 |
2013: 1 drug
| Furosemide | 13 | $46 | $4 |
Money from drug and device companies
$525 in 2023
A payment is not proof that care is biased.
| Natus Medical | None | $525 | 1 payment
|
See the published payment
| Natus Medical | Honoraria · 2023-11-08 | None | $525 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1174899512
- Licence
- CA A150153, NY 284462California A150153: Current · expires 2027-05-31
- Group
- Cep America - Neurology PC · Wyckoff Professional Medical Services PC
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Neurology (2084N0400X); Federal specialty code 2084N0402X (2084N0402X); General practice (208D00000X)
- Mailing address
- 223 E 34th St, New York, NY, 10016
- NPI first listed
- 2012-03-29
- NPI last updated
- 2023-03-08
- NPI record certified
- 2023-03-08
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.